← Open Payments lookup

ERIN FUSCO: Open Payments

NPI 1952420416 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$459 in 14 payments from 12 companies in 2025. Trend: 2023 $19 · 2024 $676 · 2025 $459

Food & beverage: $459
CompanyPaymentsAmount
GlaxoSmithKline, LLC.1$125
Novartis Pharmaceuticals Corporation2$67
Amgen Inc.1$58
JAZZ PHARMACEUTICALS INC.2$35
Rigel Pharmaceuticals, Inc.1$28
AstraZeneca Pharmaceuticals LP1$28
ABBVIE INC.1$24
E.R. Squibb & Sons, L.L.C.1$23
Astellas Pharma US Inc1$23
Bayer Healthcare Pharmaceuticals Inc.1$19

Products named: OJJAARA, Fabhalta, BLINCYTO, ZEPZELCA, TAVALISSE, TAGRISSO, IMBRUVICA, OPDIVO.

Industry payments across NY — which companies pay providers there.